Biotechnology News 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 40.
ImmusanT Raises $20M In Series A Financing To Advance Immunotherapeutic And Diagnostic For Celiac Disease
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ImmusanT, Inc. announced today it has raised $20 million in Series A financing from Vatera Healthcare Partners LLC to advance development of the biotechnology company's immunotherapeutic vaccine Nexvax2®, companion diagnostic and monitoring tool for celiac disease.
Source: Pharmaceutical Online News - December 13, 2011 Category: Pharmaceuticals Source Type: news
Goldman buys 6.47% in Max India from WarburgEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Goldman Sachs has bought a 6.47% stake in Max India Ltd, raising its total shareholding in the insurance and healthcare company to 15.6%.
Source: The Economic Times Healthcare and Biotech News - December 12, 2011 Category: Pharmaceuticals Source Type: news
ICON Acquires BeijingWits Medical Consulting LtdEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Acquisition Strengthens ICON's Presence & Capabilities
in China
DUBLIN--(BUSINESS WIRE)--Dec 12, 2011 - ICON plc, (NASDAQ:
ICLR; ISIN: IE0005711209), a global provider of outsourced
development services to the pharmaceutical, biotechnology...
Source: Drugs.com - Pharma News - December 12, 2011 Category: Pharmaceuticals Source Type: news
Electric Eye: Retina Implant Research Expands in Europe, Seeks FDA Approval in U.S.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Promising treatments for those blinded by an often-hereditary, retina-damaging disease are expanding throughout Europe and making their way across the pond, offering a ray of hope for the hundreds of thousands of people in the U.S. left in the dark by retinitis pigmentosa . The disease--which affects about one in 4,000 people in the U.S. and about 1.5 million people worldwide --kills the retina's photoreceptors, the rod and cone cells that convert light into electrical signals, which are transmitted via the optic nerve to the brain's visual cortex for processing. [More]
Source: Scientific American Topic - Biotechnology - December 12, 2011 Category: Biotechnology Tags: Technology,Health,Mind & Brain,Medical Technology,More Science,Biotechnology,Biotechnology,Biology Source Type: news
Fortis Healthcare down 25% since intra-group dealEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
At $665 million, the listed Indian entity is paying $115 million, or 20%, more to buy the unlisted overseas healthcare business owned by its promoters.
Source: The Economic Times Healthcare and Biotech News - December 11, 2011 Category: Pharmaceuticals Source Type: news
Max Healthcare starts blackberry app for patientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Max Healthcare has rolled out a unique solution to help its patients reach out to their doctors, even at odd hours, with just one click on their BlackBerry phones.
Source: The Economic Times Healthcare and Biotech News - December 11, 2011 Category: Pharmaceuticals Source Type: news
Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data At CTRC-AACR San Antonio Breast Cancer SymposiumEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from ongoing Phase II clinical trials of Puma's investigational drug PB272 (neratinib) were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium that is currently taking place in San Antonio, Texas...
Source: Health News from Medical News Today - December 10, 2011 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Debating Genetically Modified SalmonEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Biotech company AquaBounty has not yet received FDA approval for its fast-growing, genetically-modified salmon. Biotechnologist Alison Van Eenennaam and environmental scientist Anne Kapuscinski discuss the food safety and environmental concerns associated with transgenic fish.» E-Mail This » Add to Del.icio.us
Source: NPR Health and Science - December 9, 2011 Category: Consumer Health News Source Type: news
Contagion: Controversy Erupts over Man-Made Pandemic Avian Flu VirusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
It’s a rare kind of research that incites a frenzied panic before it’s even published. But it’s flu season, and influenza science has a way of causing a stir this time of year. [More]
Source: Scientific American Topic - Biotechnology - December 9, 2011 Category: Biotechnology Tags: Health,Environment,Society & Policy,Everyday Science,Ethics,Evolution,Evolutionary Biology,Biotechnology,Biotechnology,Biology,More Science Source Type: news
Galena Biopharma Presents Phase 2 Trial Design for NeuVax(TM) (E75 + GM-CSF) Combined With Herceptin(R) (Trastuzumab) at the 34th Annual CTRC-AACR San Antonio Breast Cancer SymposiumEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LAKE OSWEGO, Ore., Dec. 9, 2011 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today presented the trial design for the upcoming Phase 2 combination trial with NeuVax(tm) (E75 plus GM-CSF) and Herceptin(r) (trastuzumab; Genentech/Roche) at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The event is being held December 6-10, 2011 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
Source: Medical News (via PRIMEZONE) - December 9, 2011 Category: Pharmaceuticals Source Type: news
On the road to creating an affordable master instrumentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Swiss Federal Laboratories for Materials Science and Technology (EMPA)) Violins made of wood treated with fungus need not hide their lights when compared to a Stradivarius, as a blind test has already demonstrated. However, these tonal masterpieces are only available as individually-made instruments. In order that these biotech violins may be manufactured in larger numbers, Empa researchers are currently working on optimizing and standardizing the fungal treatment. Financial support for the project is being provided by a generous new sponsor, the Walter Fischli Foundation.
Source: EurekAlert! - Biology - December 9, 2011 Category: Biology Source Type: news
CRD announces new partnership with PubMed HealthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(University of York) A new partnership between the Center for Reviews and Dissemination at the University of York and PubMed Health, the new online service provided by the National Center for Biotechnology Information at the US National Library of Medicine, is launched today.
Source: EurekAlert! - Medicine and Health - December 9, 2011 Category: Global & Universal Source Type: news
Norwich Soars With New CustomersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Norwich Pharmaceuticals, a provider of fullservice contract development and manufacturing for the pharmaceutical and biotech industry, announced recently that new business partnerships secured during the fourth quarter will generate significant revenue for the company.
Source: Pharmaceutical Online News - December 8, 2011 Category: Pharmaceuticals Source Type: news
Molecular Partners and Janssen enter research collaboration dealEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Molecular Partners has signed a strategic research collaboration with Janssen Biotech, for designed ankyrin repeat protein (DARPin) products for the treatment of immunological diseases.
Source: Drug Development Technology - December 8, 2011 Category: Pharmaceuticals Source Type: news
Minimization and Prevention of Phage Infections in BioprocessesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Phage infections in bacterial bioprocesses constitute one of the most devastating threats to the productivity of the biotechnology facilities. There are several factors, which can decide if an infection would occur, and if it would turn into an outbreak and heavy contamination of the production facility. This issue is discussed on the basis of literature survey and experience of Phage Consultants.
Source: Springer protocols feed by Microbiology - December 8, 2011 Category: Microbiology Source Type: news
Using an Advanced Microfermentor System for Strain Screening and Fermentation OptimizationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Industrial biotechnology employs microorganisms (strains) for manufacture of certain food or industrial products to meet the increasing need of the world. To develop a bioproduction process, the first step is to screen out a production strain from isolated, mutated, or genetically engineered strain candidates. To maximize the bioproduction of a selected strain, bioreaction (fermentation) conditions need to be optimized. Fermentation experiments in shake flasks, bench-scale fermentors, or a combination of both are the conventional methods for both strain screening and fermentation optimization. Shake-flask experiments are e...
Source: Springer protocols feed by Microbiology - December 8, 2011 Category: Microbiology Source Type: news
Amgen Expects to Acquire 83.3M Shares in BuybackEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (December 8, 2011)
THOUSAND OAKS, Calif. -- Amgen anticipates that it will acquire
more than 9 percent of its outstanding shares in a modified Dutch
auction tender offer announced last month, the biotech drugmaker
said...
Source: Drugs.com - Pharma News - December 8, 2011 Category: Pharmaceuticals Source Type: news
Health IT leads new job markets in the makingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Despite concerns that the current drop in unemployment is temporary, the long-term numbers suggest that recent employment statistics can be attributed to an overall recovery pattern, and health IT is among the leading markets in that recovery, according to MedZilla.com, a healthcare, pharmaceutical, and biotech employment information website.
read more
Source: Healthcare IT News - December 8, 2011 Category: Information Technology Authors: Bernie Monegain Tags: Online Only Industry News information technology Johnston pharmaceutical retail Seattle Electronic Health Records Health Information Exchange (HIE) Network Infrastructure Policy and Legislation Privacy and Security Quality and Safe Source Type: news
Two Upstate Medical University projects win state economic development fundingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Central New York Biotechnology Research Center and Loguen's Crossing development share $5.6 million in state economic development support
Source: SUNY Upstate Medical - December 8, 2011 Category: Universities & Medical Training Source Type: news
Janssen Biotech, Inc. Announces Collaborative Development And Worldwide License Agreement For Investigational Anti-Cancer Drug, PCI-32765 (Dec 8, 2011)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HORSHAM, PA, (December 8, 2011) – Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE:JNJ), announced today that it has executed an agreement with Pharmacyclics, Inc. (Nasdaq: PCYC) to jointly develop and market the anti-cancer compound, PCI-32765. A number of Phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. Interim data were reported at the 2011 American Society of Clinical Oncology Annual Meeting and oral presentations o...
Source: Johnson and Johnson - December 8, 2011 Category: Pharmaceuticals Source Type: news
Manappuram Health Care to invest Rs 1000 crore in next 5 yearsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Manappuram Health Care Ltd, a venture of the Manappuram Group of Companies, would be investing nearly rs 1000 crore over the next five years.
Source: The Economic Times Healthcare and Biotech News - December 8, 2011 Category: Pharmaceuticals Source Type: news
Supercomputer Reveals New Details Behind Drug-Processing Protein ModelEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Supercomputer simulations at the Department of Energy's Oak Ridge National Laboratory are giving scientists unprecedented access to a key class of proteins involved in drug detoxification. Jerome Baudry and Yinglong Miao, who are jointly affiliated with ORNL and the University of Tennessee, have performed simulations to observe the motions of water molecules in a class of enzymes called P450s. Certain types of P450 are responsible for processing a large fraction of drugs taken by humans. The supercomputer simulations were designed to help interpret ongoing neutron experiments...
Source: Health News from Medical News Today - December 8, 2011 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news
Combating Counterfeit MedicinesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In this week's PLoS Medicine, Paul Newton of Mahosot Hospital, Vientiane, Lao PDR and the University of Oxford, UK and colleagues argue that public health issues, and not intellectual property or trade issues, should be the prime consideration in defining and combating counterfeit medicines. They say that the World Health Organization (WHO) should take a more prominent role. The authors advocate that an international treaty on medicine quality, under the auspices of the WHO, could play a key role in the struggle against counterfeit and substandard medicines...
Source: Health News from Medical News Today - December 8, 2011 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news
Sun Pharma's Dilip Shanghvi buys stake in Natco Pharma for 18.34 crEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Natco shares surged 15% to 278.6, coinciding with the company's sale of shares to institutional investors under the qualified institutional buyers' plan.
Source: The Economic Times Healthcare and Biotech News - December 7, 2011 Category: Pharmaceuticals Source Type: news
ikfe CRO - Full-Service Contract Research OrganisationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As a German-based full-service contract research organisation, ikfe CRO provides a wide range of services to pharmaceutical and biotechnology companies across the world.
Source: Drug Development Technology - December 7, 2011 Category: Pharmaceuticals Source Type: news
Rate your Duchenne/Becker care through the Clinic SurveyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The MD-CARE Act was signed into law in 2001 and reauthorized in 2008. What’s that got to do with a clinic survey you might ask? The MD-CARE Act was a pivotal moment. In a certain way, it was nearly as important as the identification of the dystrophin gene. The hearing was the first time Duchenne was said out loud in Congress. Duchenne was on the NIH radar, as well as, CDC. What you might not know about are all the meetings leading up to the passage of that legislation.
One meeting was with the CDC. It was pretty clear we had NO natural history of Duchenne, other than a study from many years earlier when steroids were...
Source: Parent Project Muscular Dystrophy - December 7, 2011 Category: Neurology Authors: Pat Furlong Source Type: news
Galena Biopharma Presents 5 Year NeuVax(TM) Efficacy Data at the 34th Annual CTRC-AACR San Antonio Breast Cancer SymposiumEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LAKE OSWEGO, Ore., Dec. 7, 2011 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced five year efficacy data from the ongoing NeuVax(tm) Phase 2 trial at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The event is being held December 6-10, 2011 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
Source: Medical News (via PRIMEZONE) - December 7, 2011 Category: Pharmaceuticals Source Type: news
PolyMedix Announces Encouraging Interim Results From Multinational Phase 2 Clinical Trial With PMX-30063 Defensin-Mimetic AntibioticEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RADNOR, Pa., Dec. 7, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that an interim analysis of results from more than 80 patients enrolled in its Phase 2 clinical trial with PMX-30063 defensin-mimetic antibiotic, indicate that all dosing arms in the study were both safe and effective in treating patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) caused by S. aureus. This is the first ever patient clinical efficacy study conducted with...
Source: Medical News (via PRIMEZONE) - December 7, 2011 Category: Pharmaceuticals Source Type: news
ikfe CRO-Diabetes and Cardiovascular Research ExpertsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ikfe CRO provides a wide range of services to pharmaceutical and biotechnology companies across the world. As a German-based full service contract research organisation, our pharmaceutical product de...
Source: Drug Development Technology - December 6, 2011 Category: Pharmaceuticals Source Type: news
Prescriptions Blog: New Breast Cancer Test May Help Curtail TreatmentsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Genomic Health is planning to release results of the test's accuracy on Thursday at a breast cancer symposium.
Source: NYT Health - December 6, 2011 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Breast Cancer diagnostic tests Genomic Health biotechnology Source Type: news
2011 Nobel Laureate Ralph Steinman Explains Discovery of Cells Used for Cancer Treatment [Video]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In the quest to cure cancer, many researchers have started looking beyond toxic chemicals and harsh radiation and instead are trying to harness the body's immune system. [More]
Source: Scientific American Topic - Biotechnology - December 6, 2011 Category: Biotechnology Tags: Health,Biotechnology,More Science,Biotechnology,Biology,Health Source Type: news
bioMérieux - Information on 2011 sales objectiveEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
bioMérieux, a world leader in the field of in vitro diagnostics,announces that, based on preliminary data, sales growth at constant exchange rates, for the eleven months ended November 30, 2011, amounted to 5.5%, with 3.4% organic growth. The deteriorating market conditions are impacting the acceleration of sales expected at the end of the year.
Source: bioMerieux Press Releases - December 6, 2011 Category: Biotechnology Source Type: news
Competition Entries Invited For Award At Pharma Packaging & Labelling Compliance ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Anti-counterfeiting, packaging safely via redesign, 2D barcoding integrity and artwork management updates are just a few among the major themes of Fleming Europe's 2nd Annual Pharma Packaging & Labeling Compliance Conference which is once again bringing you three days of ground-breaking debate and pioneering case studies from top industry, regulatory and association experts...
Source: Health News from Medical News Today - December 6, 2011 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news
New Dimensions In Flexel® For Magnetic MixersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sartorius Stedim Biotech presents 1,500 L and 2,000 L standard single-use mixing systems for large volumes.
Source: Pharmaceutical Online News - December 6, 2011 Category: Pharmaceuticals Source Type: news
New Dimensions In Flexel For Magnetic MixersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sartorius Stedim Biotech presents 1,500 L and 2,000 L standard single-use mixing systems for large volumes.
Source: Pharmaceutical Online News - December 6, 2011 Category: Pharmaceuticals Source Type: news
Galena Biopharma Enters Into Exchange Agreements With Warrant HoldersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LAKE OSWEGO, Ore., Dec. 6, 2011 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced it has entered into separate exchange agreements with several institutional holders of its outstanding warrants to surrender for cancellation of some of the warrants having "ratchet" price-based anti-dilution protection features in exchange for shares of Company common stock.
Source: Medical News (via PRIMEZONE) - December 6, 2011 Category: Pharmaceuticals Source Type: news
PolyMedix Launches New WebsiteEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RADNOR, Pa., Dec. 6, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTC BB:PYMX), a clinical-stage biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, is pleased to announce the launch of its redesigned company website at www.polymedix.com. The enhanced site captures the Company's mission to develop innovative and cost-effective drug therapies for life-threatening acute conditions where there is a significant unmet medical need. Additionally, there is extensive information on PolyMedix's two lead products, which are currently being e...
Source: Medical News (via PRIMEZONE) - December 6, 2011 Category: Pharmaceuticals Source Type: news
Trinity Biotech Announces FDA Approval of Premier Hb9210Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DUBLIN, Ireland, Dec. 6, 2011 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has obtained FDA approval for the Premier Hb9210.
Source: Medical News (via PRIMEZONE) - December 6, 2011 Category: Pharmaceuticals Source Type: news
Solving Biotech's "Asymmetry of Maturity" ChallengeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Biotech’s high risks have led to the conventional wisdom that it’s valuable to construct a diversified portfolio of products at the company level. Reinforced by the “show me multiple shots on goal” mantra of the capital markets, many product-focused biotech companies staple together multiple assets with the hope that one of them hits. This storyline has been essential for most IPOs in the past decade. However, while conceptually appealing on the surface, building this diverse portfolio inside a single corporate structure often creates real practical challenges down the road.
Source: Forbes.com Healthcare News - December 5, 2011 Category: Pharmaceuticals Authors: Bruce Booth Source Type: news
Egg Timer: Separate Biological Clocks Govern Female Fertility and Life SpanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As a biological feat, it was the equivalent of an 80-year-old woman giving birth: Because of a mutation, Coleen Murphy's worms were still fertile and laying eggs right up until the end of their lives. The worms' impressive performance adds weight to the evidence that the biological clock that rules reproduction is separate from the one that grants us the traditional threescore and 10. [More]
Source: Scientific American Topic - Biotechnology - December 5, 2011 Category: Biotechnology Tags: Health,Biotechnology,More Science,Biotechnology,Biology,Society & Policy Source Type: news
Insects Find Crack In Biotech Corn's ArmorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists report that a genetically engineered corn crop has failed to kill the corn rootworm — the pest it was designed to stop. This may be the most serious threat to a genetically modified crops in the U.S. since farmers first started growing them fifteen years ago.» E-Mail This » Add to Del.icio.us
Source: NPR Health and Science - December 5, 2011 Category: Consumer Health News Source Type: news
FDA to Approve New Generics, But Health Care Savings Will Be MinimalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In 1984 the Hatch-Waxman Act made it cheaper and easier to put generic versions of a drug on the market. As a result of the expedited approval process, generics now make up more than 60 percent of prescription drugs sold in the U.S. and have saved the health care system $734 billion between 1999 and 2008 alone. [More]
Source: Scientific American Topic - Biotechnology - December 5, 2011 Category: Biotechnology Tags: Health,Pharmaceuticals,Biotechnology,Health,Biotechnology Source Type: news
Ribosome Display for the Selection of Sac7d ScaffoldsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We describe here the methodology for the construction of a library of Sac7d and its use for selection by ribosome display.
Source: Springer protocols feed by Protein Science - December 5, 2011 Category: Biochemistry Source Type: news
Update on Pure Translation Display with Unnatural Amino Acid IncorporationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The identification of peptide and protein ligands by directed evolution in vitro has been of enormous utility in molecular biology and biotechnology. However, the translation step in almost all polypeptide selection methods is performed in vivo or in crude extracts, restricting applications. These restrictions include a limited library size due to transformation efficiency, unwanted competing reactions in translation, and an inability to incorporate multiple unnatural amino acids (AAs) with high fidelity and efficiency. These restrictions can be addressed by “pure translation display” where the translation step...
Source: Springer protocols feed by Protein Science - December 5, 2011 Category: Biochemistry Source Type: news
UK invests £75 million in European research infrastructure to support knowledge-based economyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(European Molecular Biology Laboratory - European Bioinformatics Institute) The European Molecular Biology Laboratory's European Bioinformatics Institute and the Biotechnology and Biological Sciences Research Council warmly welcome today's announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills' Large Facilities Capital Fund for the ELIXIR research infrastructure.
Source: EurekAlert! - Medicine and Health - December 5, 2011 Category: Global & Universal Source Type: news
Drug research calls for shot of vitalityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The UK sector's global appeal is in decline and fresh policy is imminent to help biotechnology and pharmaceutical companies
Source: FT.com - Drugs and Healthcare - December 4, 2011 Category: Pharmaceuticals Source Type: news
Scalable Amounts Of Liver And Pancreas Precursor Cells Created Using New Stem Cell Production MethodEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Scientists in Canada have overcome a key research hurdle to developing regenerative treatments for diabetes and liver disease with a technique to produce medically useful amounts of endoderm cells from human pluripotent stem cells. The research, published in Biotechnology and Bioengineering, can be transferred to other areas of stem cell research helping scientists to navigate the route to clinical use known as the 'valley of death'...
Source: Health News from Medical News Today - December 3, 2011 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news
Ranbaxy Laboratories falls on payment concerns to Teva Pharmaceuticals, delay in settlment with FDAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ranbaxy's share price fell 1.66% due to concerns about payment to Teva Pharmaceuticals and delay in settlement with US authorities.
Source: The Economic Times Healthcare and Biotech News - December 2, 2011 Category: Pharmaceuticals Source Type: news
Human Genome Untangled in 3-D [Video]Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Erez Lieberman Aiden was an undergraduate at Princeton University in 2000 when scientists announced with great fanfare that they had sequenced the first human genome , yielding a trove of information about what happens inside every human cell. But Aiden wondered what it would be like to see what was happening inside a human cell. How does this gigantic genome--which would stretch 2 meters if you unwound it from its 5-micron-wide coil in the nucleus--actually go about its work? [More]
Source: Scientific American Topic - Biotechnology - December 2, 2011 Category: Biotechnology Tags: Health,Health,Math,Medical Technology,More Science,Evolutionary Biology,Biotechnology,Biotechnology,Biology,Technology Source Type: news
